LRIG3
Reactivité: Humain, Souris
WB, ELISA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
For WB starting dilution is: 1:2000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.44 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Antigène
LRIG3
(Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))
anticorps LRIG3, anticorps lrig3, anticorps GB17149, anticorps LIG3, anticorps 9030421L11Rik, anticorps 9130004I02Rik, anticorps 9430095K15Rik, anticorps mKIAA3016, anticorps RGD1561255, anticorps leucine rich repeats and immunoglobulin like domains 3, anticorps leucine-rich repeats and immunoglobulin-like domains 3, anticorps leucine-rich repeats and immunoglobulin-like domains protein 3, anticorps leucine-rich repeats and immunoglobulin like domains 3 S homeolog, anticorps leucine-rich repeats and immunoglobulin like domains 3, anticorps LRIG3, anticorps lrig3, anticorps LOC726128, anticorps lrig3.S, anticorps Lrig3
Sujet
May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity).